🇳🇴
NordicsNorway
Norway's biotech sector is concentrated in Oslo, with strong expertise in radiopharmaceuticals, diagnostics, and immunotherapy. Companies like Algeta (acquired by Bayer for $2.9B) have proven the Norwegian ecosystem can produce world-class biotech.
Biotech Market Cap
$326.8M
Public Companies
4
Total Companies
53
30D Performance
-11.71%
BIOTECH MARKET CAP INDEX
$326.8M+150.4%ALL
BIOTECH HUBS
OsloBergenTrondheimTromsø
COMPANIES
| # | Company | Valuation |
|---|---|---|
| 1 |  | $104.3M |
| 2 |  | $101.5M |
| 3 |  | $100.7M |
| 4 |  | $20.4M |
| 5 |  | — |
| 6 |  | — |
| 7 |  | — |
| 8 |  | — |
| 9 |  | — |
| 10 |  | — |
| 11 |  | — |
| 12 |  | — |
| 13 | | — |
| 14 |  | — |
| 15 |  | — |
| 16 |  | — |
| 17 |  | — |
| 18 |  | — |
| 19 |  | — |
| 20 |  | — |
Showing 1–20 of 53 companies
Page 1 of 3